In the boardrooms of 2026, the conversation around capital allocation has shifted decisively. For decades, corporate health insurance was viewed as a necessary line item—a cost of doing business that eroded margins and offered little strategic advantage. That calculus has been inverted. The most sophisticated CFOs and institutional investors now…

The convergence of biometric data and financial planning has ushered in a paradigm shift that few predicted a decade ago. In 2026, the line between managing one’s health and managing one’s wealth has not only blurred—it has nearly vanished. High-net-worth individuals and financially savvy consumers are no longer content with…